SCHEMBL15028259

SCHEMBL15028259

Clc1cc2c(-c3ccccc3)c3c(c(-c4ccccc4)c2cc1Br)-c1cccc2c(-c4ccc5c6c(cccc46)-c4ccccc4-5)ccc-3c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HKDC1 Q2TB90 1/20 0.40
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
KEAP1 Q14145 1/20 0.35
NFE2L2 Q16236 1/20 0.35
ALDH1A1 P00352 3/20 0.34
TSHR P16473 2/20 0.34
MAPK1 P28482 2/20 0.34
HPGD P15428 2/20 0.34
CASP1 P29466 1/20 0.34
HIF1A Q16665 1/20 0.34
HSD17B10 Q99714 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1B1 Q16678 4/20 0.34
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33
CYP1A2 P05177 2/20 0.33
MAPT P10636 2/20 0.33
POLB P06746 1/20 0.33
ERCC1 P07992 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14680277 0.92 CA12 (0.35) HKDC1ALDH1A1TSHRMAPK1HPGD
SCHEMBL15028274 0.88 BCL2 (0.35) HKDC1ALDH1A1MAPK1THRATHRB
SCHEMBL15028275 0.85 HKDC1 (0.30) HKDC1
SCHEMBL14680405 0.85 ALDH1A1 (0.37) ALDH1A1TSHRMAPK1HPGDCASP1
SCHEMBL14680398 0.82 CYP1A2 (0.33) ALDH1A1MAPK1HPGDHSD17B10L3MBTL1
SCHEMBL21851697 0.80 ALDH1A1 (0.40) CRHBPCRHR2KEAP1NFE2L2ALDH1A1
SCHEMBL14820667 0.78 THRA (0.35) ALDH1A1TSHRMAPK1HPGDCASP1
SCHEMBL12449293 0.78 CYP1A2 (0.45) HKDC1CRHBPCRHR2KEAP1NFE2L2
SCHEMBL21889355 0.78 ALDH1A1 (0.38) ALDH1A1TSHRMAPK1HPGDCASP1
SCHEMBL14732734 0.78 ERBB2 (0.32) CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170133598-A1 NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE CANON KK (JP) 2017-05-11 US disclosed
US-20170133598-A1 NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE CANON KK (JP) 2017-05-11 US disclosed
EP-2788306-B1 NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE CANON KK (JP) 2017-05-03 EP disclosed
US-9590199-B2 Organic compound, organic light emitting device, and image display device CANON KABUSHIKI KAISHA (JP) 2017-03-07 US disclosed
US-9590199-B2 Organic compound, organic light emitting device, and image display device CANON KABUSHIKI KAISHA (JP) 2017-03-07 US disclosed
US-20140374723-A1 NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE CANON KABUSHIKI KAISHA (JP) 2014-12-25 US disclosed
US-20140374723-A1 NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE CANON KABUSHIKI KAISHA (JP) 2014-12-25 US disclosed
WO-2013084833-A1 NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE CANON KABUSHIKI KAISHA (JP) 2013-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170133598-A1 NOVEL ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE, AND IMAGE DISPLAY DEVICE OCIAD1, OCIAD2, OXER1 HKDC1 2649/4885CRHBP 4698/4885CRHR2 4265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.